Probing the role of homomeric and heteromeric receptor interactions in TGF-β signaling using small molecule dimerizers

Current Biology

Volumn 8, Issue 13, 1998, Pages 761-773

  Stockwell, Brent R ^a   Schreiber, Stuart L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MUSTELA VISON;

EID: 0032543664     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(98)70299-4     Document Type: Article

References (70)

1. Massague J, Weis-Garcia F: Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv 1996, 27:41-64.
2. Bassing CH, Howe DJ, Segarini PR, Donahoe PK, Wang X-F: A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-β ligands. J Biol Chem 1994, 269:14861-14864.
3. Feng X-H, Filvaroff EH, Derynck R: Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J Biol Chem 1995, 270:24237-24245.
4. Brand T, Schneider MD: Inactive type II and type I receptors for TGFβ are dominant inhibitors of TGFβ-dependent transcription. J Biol Chem 1995, 270:8274-8284.
5. Bassing CH, Yingling JM, Wang X-F: Receptors for the TGF-β ligand family. Vitam Horm 1994, 48:111-156.
6. Inagaki M, Moustakas A, Lin HY, Lodish HF, Carr BI: Growth inhibition by transforming growth factor β (TGF-β) type I is restored in TGF-β resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc Natl Acad Sci USA 1993, 90:5359-5363.
7. Boyd FT, Massague J: Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J Biol Chem 1989, 264:2272-2278.
8. Laiho M, Weis FMB, Massague J: Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem 1990, 265:18518-18524.
9. Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C-H, et al.: Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 1993, 75:681-692.
10. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF: Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992, 68:775-785.
11. Lopez-Casillas F, Wrana JL, Massague J: Betaglycan presents ligand to the TGFβ signaling receptor. Cell 1993, 73:1435-1444.
12. Liu Q, Huang SS, Huang JS: Function of the type V transforming growth factor β receptor in transforming growth factor β-induced growth inhibition of mink lung epithelial cells. J Biol Chem 1997, 272:18891-18895.
13. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J: Mechanism of activation of the TGF-β receptor. Nature 1994, 370:341-347.
14. Luo K, Lodish HF: Positive and negative regulation of type II TGF-β receptor signal transduction by autophosphorylation on multiple serine residues. EMBO J 1997, 16:1970-1981.
15. Lawler S, Feng X-H, Chen R-H, Maruoka M, Turck CW, Griswold-Prenner I, et al.: The type II transforming growth factor-β receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem 1997, 272:14850-14859.
16. Yamashita H, ten Dijke P, Franzen P, Miyazono K, Heldin C-H: Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem 1994, 269:20172-20178.
17. Ebner R, Chen RH, Lawler S, Ziocheck T, Derynck R: Determination of type I receptor specificity by the type II receptors for TGF-β or activin. Science 1993, 262:900-902.
18. Chen F, Weinberg RA: Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. Proc Natl Acad Sci USA 1995, 92:1565-1569.
19. Lin HY, Moustakas A, Knaus P, Well RG, Henis YI, Lodish HF: The soluble exoplasmic domain of the type II transforming growth factor (TGF)-β receptor. J Biol Chem 1995, 270:2747-2754.
20. Bassing CH, Yingling JM, Howe DJ, Wang TW, He WW, Gustafson ML, et al.: A transforming growth factor β type I receptor that signals to activate gene expression. Science 1994, 263:87-89.
21. Persson U, Souchelnytskyi S, Franzen P, Miyazono K, ten Dijke P, Heldin C-H: Transforming growth factor beta (TGF-β)-specific signalling by chimeric TGF-β type II receptor with intracellular domain of activin type IIB receptor. J Biol Chem 1997, 272:21187-21194.
22. Wieser R, Wrana JL, Massague J: GS domain mutations that constitutively activate TβRI, the downstream signaling component in the TGF-β receptor complex. EMBO J 1995, 14:2199-2208.
23. Feng X-H, Derynck R: A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-β intracellular signaling specificity. EMBO J 1997, 16:3912-3923.
24. Carcamo J, Zentella A, Massague J: Disruption of transforming growth factor β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol Cell Biol 1995, 15:1573-1581.
25. Zhang Y, Feng X-H, Wu R-Y, Derynck R: Receptor-associated mad homologues synergize as effectors of the TGF-β response. Nature 1996, 383:168-172.
26. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL: MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 1996, 87:1215-1224.
27. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, et al.: TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J 1997, 16:5353-5362.
28. Lagna G, Hata A, Hemmati-Brivanlou A, Massague J: Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways. Nature 1996, 383:832-836.
29. Graff JM, Bansal A, Melton DA: Xenopus mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 1996, 85:479-487.
30. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, et al.: Smad6 inhibits signaling by the TGF-β superfamily. Nature 1997, 389:622-626.
31. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, et al.: Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signaling. Nature 1997, 389:631-635.
32. Hata A, Lagna G, Massague J, Hemmati-Brivanlou A: Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 1998, 12:186-197.
33. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF: Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 1997, 94:10669-10674.
34. de Caestecker MP, Hemmati P, Larisch-Bloch S, Ajmera R, Roberts AB, Lechleider RJ: Characterization of functional domains within Smad4/DPC4. J Biol Chem 1997, 272:13690-13696.
35. de Winter JP, Roelen BAJ, ten Dijke P, van der Burg B, van den Eijnden-van Raaji AJM: DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 1997, 14:1891-1900.
36. Baker JC, Harland RM: A novel mesoderm inducer, MADR2, functions in the activin signal transduction pathway. Genes Dev 1996, 10:1880-1889.
37. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM, et al.: A human mad protein acting as a BMP-regulated transcriptional activator. Nature 1996, 381:620-623.
38. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Conner MB, Attisano L, et al.: MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 1996, 85:489-500.
39. Liu F, Pouponnot C, Massague J: Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes. Genes Dev 1997, 11:3157-3167.
40. Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M: Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 1997, 389:85-89.
41. Chen X, Rubock MJ, Whitman M: A transcriptional partner for MAD proteins in TGF-β signaling. Nature 1996, 383:691-696.
42. Clark KL, Halay ED, Lai E, Burley SK: Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 1993, 364:412-420.
43. Kim J, Johnson K, Chen HJ, Carroll S, Laughon A: Drosophila mad binds to DNA and directly mediates activation of vestigial by decapentaplegic. Nature 1997, 388:304-308.
44. Henis YI: The types II and III transforming growth factor-β receptors form homo-oligomers. J Cell Biol 1994, 126:139-154.
45. Chen RH, Derynck R: Homomeric interactions between type II transforming growth factor-β receptors. J Biol Chem 1994, 269:22868-22874.
46. Letourneur O, Goetschy JF, Horisberger M, Grutter MG: Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II. Biochem Biophys Res Commun 1996, 224:709-716.
47. Luo K, Lodish HF: Signaling by chimeric erythropoietin-TGF-β receptors: homodimerization of the cytoplasmic domain of the type I TGF-β receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. EMBO J 1996, 15:4485-4496.
48. Weis-Garcia F, Massague J: Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signalling. EMBO J 1996, 15:276-289.
49. Spencer DM, Wandless TJ, Schreiber SL, Crabtree GR: Controlling signal transduction with synthetic ligands. Science 1993, 262:1019-1024.
50. Stockwell BR, Schreiber SL: TGF-β signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-β type I receptor fusion proteins. Chem Biol 1998, 5:in press.
51. Yang D, Rosen MK, Schreiber SL: A composite FKBP12-FK506 surface that contacts calcineurin. J Am Chem Soc 1993, 115:819-820.
52. Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, et al.: A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994, 369:756-758.
53. Liberles SD, Diver ST, Austin DJ, Schreiber SL: Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc Natl Acad Sci USA 1997, 94:7825-7830.
54. Chen J, Zheng X-F, Brown EJ, Schreiber SL: Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc Natl Acad Sci USA 1995, 92:4947-4951.
55. Diver ST, Schreiber SL: Single-step synthesis of cell-permeable protein dimerizers that activate signal transduction and gene expression. J Am Chem Soc 1997, 119:5106-5109.
56. Belshaw PJ, Spencer DM, Crabtree GR, Schreiber SL: Controlling programmed cell death with a cyclophilin-cyclosporin-based chemical inducer of dimerization. Chem Biol 1996, 3:731-738.
57. Belshaw PJ, Ho SN, Crabtree GR, Schreiber SL: Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci USA 1996, 93:4604-4607.
58. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, et al.: TGFβ signals through a heteromeric protein kinase receptor complex. Cell 1992, 71:1003-1014.
59. Chen RH, Moses HL, Maruoka EM, Derynck R, Kawabata M: Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-β receptors. J Biol Chem 1995, 270:12235-12241.
60. Feng X-H, Derynck R: Ligand-independent activation of transforming growth factor (TGF) β signaling pathways by heteromeric cytoplasmic domains of TGF-β receptors. J Biol Chem 1996, 271:13123-13129.
61. Yang J, Symes K, Mercola M, Schreiber SL: Small-molecule control of insulin and PDGF receptor signaling and the role of membrane attachment. Curr Biol 1998, 8:11-18.
62. Wells RG, Yankelev H, Lin HY, Lodish HF: Biosynthesis of the type I and type II TGF-β receptors. J Biol Chem 1997, 272:11444-11451.
63. Koli M, Arteaga CL: Processing of the transforming growth factor β type I and II receptors. J Biol Chem 1997, 272:6423-6427.
64. Anders RA, Leof EB: Chimeric granulocyte/macrophage colony-stimulating factor/transforming growth factor-β (TGF-β) receptors define a model system for investigating the role of homomeric and heteromeric receptors in TGF-β signaling. J Biol Chem 1996, 271:21758-21766.
65. Vivien D, Attisano L, Wrana JL, Massague J: Signaling activity of homologous and heterologous transforming growth factor-β receptor kinase complexes. J Biol Chem 1995, 270:7134-7141.
66. Souchelnytskyi S, ten Dijke P, Miyazono K, Heldin C-H: Phosphorylation of ser165 in TGF-β type I receptor modulates TGF-β1-induced cellular responses. EMBO J 1996, 15:6231-6240.
67. Saitoh M, Nishitoh H, Amagasa T, Miyazono K, Takagi M, Ichijo H: Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-β. J Biol Chem 1996, 271:2769-2775.
68. Carcamo J, Weis FMB, Ventura F, Wieser R, Wrana JL, Attisano L, et al.: Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol Cell Biol 1994, 14:3810-3821.
69. Spencer DM, Belshaw PJ, Chen L, Ho SN, Randazzo F, Crabtree GR, et al.: Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization. Curr Biol 1996, 6:839-847.
70. Belshaw PJ, Schoepfer J, Liu K, Morrison K, Schreiber SL: Rational design of orthogonal receptor-ligand combinations. Angew Chem, Int Ed Eng 1995, 34:2129-2132.